News

AddToAny

Google+ Facebook Twitter Twitter

Optical biopsy system for liver cancer

Researchers have developed an optical biopsy system that can distinguish between cancerous and healthy liver tissue.

The new technology could make it easier to diagnose liver cancer, which is the sixth most common cancer globally.

“The instrument is designed to be compatible with the needles currently used for liver biopsies,” said Evgenii Zherebtsov, a member of the research team.

“It could thus one day help surgeons more precisely navigate the biopsy instrument to decrease the number of errors in taking tissue samples that are used for diagnosis.”

The researchers report that the optical biopsy system can reliably distinguish between cancerous and healthy cells in mouse models.

The system also showed promise in preliminary tests conducted in people with suspected liver cancer.

The new optical biopsy system combines diffuse reflectance spectroscopy and lifetime fluorescence measurements to evaluate markers related to cellular metabolism, which differs between healthy and cancerous cells.

bit.ly/3tcwnRb

Related Articles

My lab: A bespoke state-of-the-art lab

Alix Costello gives a guided tour of the laboratory facilities at Blackpool Victoria Hospital.

“Collagen a key player in breast cancer metastasis”

Collagen type XII plays a key role in regulating the organisation of the tumour matrix, reveals a new study.

Frozen testicular tissue still viable after two decades

Male testis tissue that is cryopreserved can be reimplanted after more than 20 years and will make viable sperm, according to a new study in rodents.

AI can predict Crohn’s disease recurring after surgery

Using an artificial intelligence (AI) tool that emulates how humans visualise and is trained to recognise and classify images, investigators constructed a model that predicts the postoperative recurrence of Crohn’s disease with high accuracy by evaluating histological images.

Top